No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Jilin Yatai (600881.SH): has cumulatively repurchased 0.09% of shares.
Gelonghui, February 6th | Jilin Yatai (600881.SH) announced that as of the end of January 2025, the company has repurchased a total of 3,027,300 shares, accounting for approximately 0.09% of the company's total share capital. The highest repurchase price was 1.66 yuan/share, the lowest price was 1.65 yuan/share, and the total amount of funds paid was 4,998,797 yuan (excluding transaction fees).
Jilin Yatai (Group) Co., Ltd. 2024 Annual Results Pre-loss Announcement
Jilin Yatai (600881.SH) has issued a profit warning, estimating a net loss of 2.8 billion yuan to 3.2 billion yuan for the year 2024.
Jilin Yatai (600881.SH) has released a preliminary loss announcement for the fiscal year 2024, expecting the company's performance in 2024 to be...
Does Jilin Yatai (Group) (SHSE:600881) Have A Healthy Balance Sheet?
Jilin Yatai (600881.SH): The State-Owned Assets Supervision and Administration Commission of Changchun intends to extend the implementation period of this shareholding plan by 6 months.
Gelonghui, December 30th丨Jilin Yatai (600881.SH) announced that it recently received a letter from the State-owned Assets Supervision and Administration Commission of Changchun City regarding the extension of the shareholding plan deadline. Based on the company's stock price fluctuations and other actual circumstances, it plans to extend the implementation period of this shareholding plan by 6 months (until June 30, 2025). Aside from the extended implementation period, the other contents of this shareholding plan remain unchanged.
Investors in Jilin Yatai (Group) (SHSE:600881) From Five Years Ago Are Still Down 60%, Even After 8.6% Gain This Past Week
